Awarded
Medicamento del LOTE 1
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- GILEAD SCIENCES, S.L.
- Contract value
- €6,373,727
- Bids received
- 1
- Published
- 24 Sept 2026
- Awarded
- 23 Sept 2026
- Contract start
- 23 Sept 2026
- Contract end
- 24 Sept 2027estimated
- Region
- Cantabria
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Medicamento del LOTE 6. | Servicio Cántabro de Salud | VERTEX PHARMACEUTICALS SPAIN, S.L. | €6,537,891 | 24 Sept 2026 |
| Medicamento del LOTE 5. | Servicio Cántabro de Salud | VERTEX PHARMACEUTICALS SPAIN, S.L. | €2,998,224 | 24 Sept 2026 |
| Medicamento del LOTE 4. | Servicio Cántabro de Salud | JANSSEN CILAG, S.A. | €14,120,000 | 24 Sept 2026 |
| Medicamento del LOTE 3. | Servicio Cántabro de Salud | BRISTOL MYERS SQUIBB, S.A.U | €1,831,680 | 24 Sept 2026 |
| Medicamento del LOTE 2. | Servicio Cántabro de Salud | NOVARTIS FARMACEUTICA, S.A. | €2,457,600 | 24 Sept 2026 |
| Lote 8. Vectibix (Panitumumab) | Servicio Cántabro de Salud | AMGEN S.A. | €2,481,004 | 23 Sept 2026 |